missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ beta Lactamase Monoclonal Antibody (3E11.G3), Invitrogen™
Description
MA1-10713 detects beta Lactamase from Enterobacter cloacae samples. MA1-10713 has been successfully used in ELISA applications. The MA1-10713 immunogen is Type IV beta-lactamase from Enterobacter cloacae .
The beta lactam antibiotics (penicillins and cephalosporins) are the most frequently used antimicrobial agents. All of the beta lactams are structurally related through the presence of a core beta lactam ring. Bacterial resistance to beta lactams continues to increase, primarily due to the production of beta lactamases. Beta lactamases catalyze the hydrolysis of the beta lactam bond, which destroys antibacterial activity. Bacteria that produce TEM type or SHV type beta lactamases have point mutations in structural genes that have extended the substrate specificity of these beta lactamases. As a result, many of the beta lactamase producing Gram negative pathogens have become multidrug resistant.
Specifications
Specifications
| Antigen | beta Lactamase |
| Applications | ELISA |
| Classification | Monoclonal |
| Clone | 3E11.G3 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene Alias | blaCTX-M-14; FLJ14902; G24; lactamase beta; LACTB; mitochondrial 39S ribosomal protein L56; MRPL56; Serine beta-lactamase-like protein LACTB, mitochondrial; UNQ843/PRO1781 |
| Host Species | Mouse |
| Immunogen | Type IV beta-lactamase from Enterobacter cloacae. |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?